4d Molecular Therapeutics In shares owned by Vanguard Group
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $53M | 2.5M | 20.99 |
| 2024-03-31 | $75M | 2.3M | 31.86 |
| 2023-12-31 | $38M | 1.9M | 20.26 |
| 2023-09-30 | $24M | 1.9M | 12.73 |
| 2023-06-30 | $36M | 2.0M | 18.07 |
| 2023-03-31 | $27M | 1.5M | 17.19 |
| 2022-12-31 | $28M | 1.3M | 22.21 |
| 2022-06-30 | $9.2M | 1.3M | 6.98 |
| 2022-03-31 | $20M | 1.3M | 15.12 |
| 2021-09-30 | $26M | 946k | 26.97 |
| 2021-06-30 | $11M | 470k | 24.12 |
| 2021-03-31 | $19M | 437k | 43.42 |
| 2020-12-31 | $404k | 10k | 40.44 |